Tocolytic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2026
- Transparency Market Research
Birth of babies before the gestational age, i.e. 37 weeks, is known as preterm birth. Preterm birth is categorized into extremely preterm (less than 28 weeks), very preterm birth (28 weeks to 31 weeks), and moderate to late preterm birth (31 weeks to 36 weeks) of gestational period. Preterm birth is the biggest problem and is primarily responsible for neonatal morbidity and mortality in the U.S. According to a 2017 report by the World Health Organization (WHO), every year, 15 million babies are born prematurely across the world and it is the most common cause of death in newborn babies. There was dramatic difference in survival of premature babies depending on where they are born. For instance, in 2017, more than 90% of extremely premature babies born in low income countries died within first few days of life, while less than 10% of extremely premature babies died in high income countries. .
Tocolytic agents are also known as anti-contraction or labor suppressant drugs. Tocolytic agents inhibit uterine contraction such as beta sympathomimetic act by relaxing and smoothing muscles contraction, calcium-channels blockers antagonize calcium within myometrial cell to reduce its contractility, magnesium sulfate displaces calcium ions prevent uterine activity, and prostaglandin synthetase inhibitor impede the release of oxytocin from the posterior pituitary gland.
The global tocolytic drugs market is driven by increase in mortality of premature babies. According to the WHO, each year, approximately 1 million babies die due to complications caused by preterm birth, multiple pregnancies, infections during pregnancy, and rise in prevalence of chronic condition such as diabetes, high blood pressure during pregnancy. However, precautionary care during birth and postnatal period, provision for antenatal steroid injections, and new techniques such as kangaroo mother care in high income countries are likely to hinder the market.
The global tocolytic drugs market can be categorized based on drug class, routes of drug administration, distribution channel, and region. In terms of drug class, the global tocolytic drugs market can be categorized into beta-sympathomimetic, calcium channel antagonist, magnesium sulphate, prostaglandin synthetase inhibitor, and others. Calcium channel antagonist is the most preferred agent due to its efficacy, fetomaternal safety, and availability. Based on route of administration, the global tocolytic drugs market can be segmented into oral, intravenous, and others. Based on distribution channels, the global market can be segmented into online pharmacies, retail pharmacies, and hospital pharmacies.
Geographically, the global tocolytic drugs market can be divided into North America, Europe, Latin America, Asia Pacific and Middle East & Africa. North America is expected to hold the largest share of the global market from 2017 to 2025 due to the higher per capita income. According to a WHO report 2017, in lower-income countries, on average, 12% of babies born too early compared with 9% in higher income countries. Europe is expected to be the second largest market due to continuous increase in research & development activities in the region. The tocolytic drugs market in Asia Pacific and Middle East & Africa is expanding at a rapid pace during the forecast period due to increase in the number of preterm births. For instance according to WHO report 2017, more than 60% of preterm births occur in Africa and Asia.
Key players operating in the global tocolytic drugs market include AstraZeneca, Bayer AG, Alkermes, Pfizer Inc., Medpharma Pharma & Chem Ind’s (L.L.C.), Solvay, Medisol Life Science Pvt. Ltd., Merit Pharmaceutical, Sandoz, Inc. (Novartis AG).
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Pharmaceutical
PharmaceuticalChinese Markets for Mental Illness Drugs
PharmaceuticalChinese Markets for Anti-Dermatomycosis Skin Drugs
PharmaceuticalChinese Markets for Incretion Drugs
PharmaceuticalChinese Markets for Hypertension Drugs
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017